Back to Search Start Over

Computer-Aided Identification and Lead Optimization of Dual Murine Double Minute 2 and 4 Binders: Structure-Activity Relationship Studies and Pharmacological Activity

Authors :
Giuseppe La Regina
Claudio Luchinat
Sandro Cosconati
Linda Cerofolini
Diego Brancaccio
Mariateresa Giustiniano
Federico Da Settimo
Stefano Giuntini
Luciana Marinelli
Ettore Novellino
Anna Messere
Sveva Pelliccia
Simona Daniele
Claudia Martini
Deborah Pietrobono
Marco Fragai
Valeria La Pietra
Sabrina Taliani
Romano Silvestri
Giustiniano, Mariateresa
Daniele, Simona
Pelliccia, Sveva
La Pietra, Valeria
Pietrobono, Deborah
Brancaccio, Diego
Cosconati, Sandro
Messere, Anna
Giuntini, Stefano
Cerofolini, Linda
Fragai, Marco
Luchinat, Claudio
Taliani, Sabrina
La Regina, Giuseppe
Da Settimo, Federico
Silvestri, Romano
Martini, Claudia
Novellino, Ettore
Marinelli, Luciana
Publication Year :
2017

Abstract

The function of p53 protein, also known as "genome guardian", might be impaired by the overexpression of its primary cellular inhibitor, the murine double minute 2 protein (MDM2). However, the recent finding that MDM2-selective inhibitors induce high levels of its homologue MDM4, prompt us to identify, through a receptor-based virtual screening on an in house database, dual MDM2/MDM4 binders. Compound 1 turned out to possess an IC50 of 93.7 and of 4.6 nM on MDM2 and MDM4, respectively. A series of compounds were synthesized to optimize its activity on MDM2. As a result, compound 12 showed low nanomolar IC50 for both targets. NMR studies confirmed the pocket of binding of 12 as predicted by the Glide docking software. Notably, 12 was able to cause concentration-dependent inhibition of cell proliferation, yielding an IC50 value of 356 ± 21 nM in neuroblastoma SHSY5Y cells and proved even to efficiently block cancer stem cell growth. The function of p53 protein, also known as "genome guardian", might be impaired by the overexpression of its primary cellular inhibitor, the murine double minute 2 protein (MDM2). However, the recent finding that MDM2-selective inhibitors induce high levels of its homologue MDM4, prompt us to identify, through a receptor-based virtual screening on an in house database, dual MDM2/MDM4 binders. Compound 1 turned out to possess an IC50 of 93.7 and of 4.6 nM on MDM2 and MDM4, respectively. A series of compounds were synthesized to optimize its activity on MDM2. As a result, compound 12 showed low nanomolar IC50 for both targets. NMR studies confirmed the pocket of binding of 12 as predicted by the Glide docking software. Notably, 12 was able to cause concentration-dependent inhibition of cell proliferation, yielding an IC50 value of 356 ± 21 nM in neuroblastoma SHSY5Y cells and proved even to efficiently block cancer stem cell growth.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....11ab6d9babf2867aaec089c6007a5db2